1. Adelaide Research & Scholarship

Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 33 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosisEvdokiou, A.; Bouralexis, S.; Atkins, G.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2001Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosisAtkins, G.; Evdokiou, A.; Bouralexis, S.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2003Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapyBouralexis, S.; Findlay, D.; Atkins, G.; Labrinidis, A.; Hay, S.; Evdokiou, A.
1999Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells is Accompanied by Induction of p21 WAF1/CIP1 and G2/M ArrestEvdokiou, A.; Raggatt, L.; Findlay, D.; Atkins, G.
2011Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2013Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markersWelldon, K.; Findlay, D.; Evdokiou, A.; Ormsby, R.; Atkins, G.
2010Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat modelLabrinidis, A.; Hay, S.; Liapis, V.; Findlay, D.; Evdokiou, A.
2011Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismAtkins, G.; Rowe, P.; Lim, H.; Welldon, K.; Ormsby, R.; Wijenayaka, A.; Zelenchuk, L.; Evdokiou, A.; Findlay, D.
2013Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse modelsLuo, K.; Ko, C.; Yue, G.; Lee, M.; Siu, W.; Lee, J.; Shum, W.; Fung, K.; Leung, P.; Li, G.; Evdokiou, A.; Lau, C.
2003The relationship between RANKL expression and osteoblast differentiation in human osteoblastsKostakis, P.; Atkins, G.; Pan, B.; Farrugia, A.; Gronthos, S.; Evdokiou, A.; Findlay, D.; Zannettino, A.; European Symposium on Calcified Tissues (30th : 2003 : Rome, Italy)

Discover